PubMed Health⌕ Search

Biomedical subjects

B McCormick

Publications and source records attributed to B McCormick.

At least 19 recordsLinked to original sources
PubMed2003

Randomized comparison of laryngeal tube with classic laryngeal mask airway for anaesthesia with controlled ventilation.

BACKGROUND: Only a prototype laryngeal tube has been compared with the classic LMA for brief periods of anaesthesia. We compared the new laryngeal tube (which had several improvements in design) with the classic LMA. METHODS: We randomly allocated 72 patients to receive either the laryngeal tube or an LMA, and compared adequacy of controlled ventilation during anaesthesia (good: clear airway without complications; fair; clear airway with complications or suboptimal airway; or failed), leak pressure and the incidence of postoperative complications. RESULTS: Insertion was successful within 2 attempts in all 36 patients for the classic LMA and in 35 patients for the laryngeal tube. The mean leak pressure for the laryngeal tube (28 cm H(2)O) was significantly greater than that for the classic LMA (21 cm H(2)O) (P<0.001; 95% CI 3.6-10.0 cm H(2)O). Ventilation was good in 25 cases, fair in 11, and failed in no patients with the classic laryngeal mask airway; and good in 23, fair in 11 and failed in two for the laryngeal tube. There was no significant difference in adequacy of ventilation between the groups. The median peak airway pressure for the laryngeal tube (17.5 cm H(2)O) was greater than that for the classic LMA (16 cm H(2)O) (difference: 2 cm H(2)O; 95% CI 0-5 cm H(2)O). There was no significant difference in the incidence and severity of the postoperative complications between the two groups. CONCLUSION: The laryngeal tube was as effective as the classic LMA during anaesthesia with controlled ventilation. There were similar operative and postoperative complications.

Adult↗
PubMed2003

An evaluation of the flexiguide introducer with the flexible laryngeal mask airway.

Insertion of the flexible Laryngeal Mask Airway has been achieved by a variety of techniques. We have evaluated the Flexiguide for aiding introduction of a flexible Laryngeal Mask Airway in 100 anaesthetised patients. We were successful in establishing a clear airway on the first attempt on 84 (84%) occasions and within two attempts in 97 (97%). The positioning of the laryngeal mask airway was assessed by five measures and was optimally placed in 85% of cases and good in 96%. A clear airway was achieved in 92% of cases. Insertion of the flexible Laryngeal Mask Airway with the Flexiguide was easy in 82 (82%) and slightly difficult in 15 (15%) of cases. Removal of the Flexiguide from the device was easy in 95 (95%) of cases. Airway manoeuvres were used to assist airway placement in 55% of cases with jaw thrust being most common. Minor complications occurred in three (3%) patients: two coughed and one experienced minor tissue trauma during mask insertion. There were no complications associated with use of the Flexiguide during the procedure or after anaesthesia. The Flexiguide is a useful tool to assist insertion of the flexible Laryngeal Mask Airway and is associated with few complications.

Adolescent↗
PubMed2003

Randomized evaluation of the performance of single-use laryngoscopes in simulated easy and difficult intubation.

BACKGROUND: Single-use laryngoscopes are becoming used more widely. METHODS: We compared six types of single-use laryngoscope with the standard Macintosh laryngoscope using the Laerdal SimMan patient simulator. Twenty anaesthetists attempted to intubate the simulator with standardized airway settings allowing a full view of the vocal cords ('easy intubation'). The airway settings were then changed so that only the posterior part of the glottis was visible ('difficult intubation') and the anaesthetists were asked to intubate the simulator again. RESULTS: The time to intubate with the standard laryngoscope was less in both easy (P<0.05) and difficult (P<0.01) intubations. The performance of five laryngoscopes during easy intubation (P<0.01) and four during difficult intubation (P<0.001) was significantly worse than that of the Macintosh. There was a significant difference in Cormack and Lehane grading between the laryngoscopes tested in both easy (P<0.05) and difficult (P<0.05) intubation. The percentage of glottic opening visible (POGO score) also differed between laryngoscopes in both the easy (P<0.01) and difficult (P<0.001) groups. The highest POGO scores were obtained with the Macintosh laryngoscope. During the difficult intubation simulation, the reusable Macintosh laryngoscope needed less use of a bougie and had fewer failed intubations than the single-use laryngoscopes, but these differences did not reach statistical significance. CONCLUSIONS: Of the laryngoscopes tested, the standard reusable Macintosh laryngoscope performed best. The Europa was the best single-use laryngoscope. Some single-use laryngoscopes tested were significantly inferior to the Macintosh. This raises concern over their use in clinical practice, particularly if intubation is difficult.

Disposable Equipment↗
PubMed2001

Mammographically detected ductal carcinoma in situ of the breast treated with breast-conserving surgery and definitive breast irradiation: long-term outcome and prognostic significance of patient age and margin status.

PURPOSE: This study was performed to determine the long-term outcome for women with mammographically detected ductal carcinoma in situ (DCIS; intraductal carcinoma) of the breast treated with breast-conserving surgery followed by definitive breast irradiation. METHODS AND MATERIALS: An analysis was performed of 422 mammographically detected intraductal breast carcinomas in 418 women from 11 institutions in North America and Europe. All patients were treated with breast-conserving surgery followed by definitive breast irradiation. The median follow-up time was 9.4 years (mean, 9.4 years; range, 0.1-19.8 years). RESULTS: The 15-year overall survival rate was 92%, and the 15-year cause-specific survival rate was 98%. The 15-year rate of freedom from distant metastases was 94%. There were 48 local failures in the treated breast, and the 15-year rate of any local failure was 16%. The median time to local failure was 5.0 years (mean, 5.7 years; range, 1.0-15.2 years). Patient age at the time of treatment and final pathology margin status from the primary tumor excision were both significantly associated with local failure. The 10-year rate of local failure was 31% for patient age < or = 39 years, 13% for age 40-49 years, 8% for age 50-59 years, and 6% for age > or = 60 years (p = 0.0001). The 10-year rate of local failure was 24% when the margins of resection were positive, 9% when the margins of resection were negative, 7% when the margins of resection were close, and 12% when the margins of resection were unknown (p = 0.030). Patient age < or = 39 years and positive margins of resection were both independently associated with an increased risk of local failure (p = 0.0006 and p = 0.023, respectively) in the multivariable Cox regression model. CONCLUSIONS: The 15-year results from the present study demonstrated high rates of overall survival, cause-specific survival, and freedom from distant metastases following the treatment of mammographically detected ductal carcinoma in situ of the breast using breast-conserving surgery and definitive breast irradiation. Younger age and positive margins of resection were both independently associated with an increased risk of local failure. The 15-year results in the present study serve as an important benchmark for comparison with other treatment modalities. These results support the use of breast-conserving surgery and definitive breast irradiation for the treatment of appropriately selected patients with mammographically detected ductal carcinoma in situ of the breast.

Adult↗
PubMed2001

Salvage treatment for local recurrence after breast-conserving surgery and radiation as initial treatment for mammographically detected ductal carcinoma in situ of the breast.

BACKGROUND: The purpose of the current study is to evaluate the outcome of salvage treatment for local recurrence after breast-conserving surgery and radiation as initial treatment for mammographically detected ductal carcinoma in situ (DCIS; intraductal carcinoma) of the breast. METHODS: An analysis was performed of 42 patients with local only first failure (n = 41) or local-regional only first failure (n = 1) after breast-conserving surgery and radiation treatment had been given for DCIS of the breast. Surgical treatment at the time of local recurrence included mastectomy (n = 37; 88%) or excision (n = 5; 12%). Adjuvant systemic therapy at the time of local recurrence was chemotherapy (n = 3; 7%), tamoxifen (n = 8; 19%), both (n = 1; 2%), none (n = 29; 69%), or unknown (n = 1; 2%). The median interval from the time of initial treatment to local recurrence was 4.8 years (range = 1.0-15.2 yrs). The median follow-up after salvage treatment was 4.5 years (range = 0.2-12.8 yrs). RESULTS: At the time of the local recurrence, 22 patients (52%) had invasive ductal carcinoma, 18 patients (43%) had DCIS, 1 patient (2%) had invasive lobular carcinoma, and 1 patient (2%) had angiosarcoma. After salvage treatment, the rate of overall survival and the rate of cause specific survival for all 42 patients were 92% at both 5- and 8-years after treatment. The rate of freedom from distant metastases was 89% at 5 and 8 years. Favorable prognostic factors after salvage treatment were DCIS as the histology of the local recurrence and mammography only as the method of detection of the local recurrence. CONCLUSIONS: The results of salvage treatment in the current study demonstrated that local recurrences were salvaged with high rates of survival and freedom from distant metastases. These results support the use of breast-conserving surgery and radiation for initial management of DCIS of the breast.

Adult↗
PubMed2001

Functionally equivalent ages and hearing levels of children with cochlear implants measured with pre-recorded stimuli.

Three groups of children undertook an interactive computer-based closed-set test of the ability to identify pre-recorded spoken words presented acoustically. The test was completed by 31/39 children with profound hearing loss who had used the Nucleus Spectra-22 cochlear-implant system for at least one year (Group A); by 30 children with normal hearing (Group B); and by 22 children with severe-profound hearing loss who used acoustic hearing aids (Group C). Among the implanted children, those who were younger when implanted and who had used their devices for longer produced higher scores (multiple-r = 0.68). Logistic regression functions were fitted to the data from Group B to describe the relationship between performance and age, and to the data from Group C to describe the relationships between performance and average hearing level (AHL) and aided threshold. By use of the regression equations, the performance of each implanted child was converted into a functionally equivalent (FE) age, an FE AHL and an FE aided threshold. Despite high variability leading to wide confidence intervals, these transformations showed that: (1) mean FE age (3.4 years) lagged mean chronological age (7.4 years), but some implanted children performed within the range expected for children with normal hearing of the same age; (2) mean FE AHL was 94 dB compared with a mean pre-implant AHL of 117 dB; (3) mean FE aided threshold was 45 dB(A) compared with a mean pre-implant aided threshold of 99 dB(A). These results confirm that implantation of appropriate candidates leads to functionally better hearing than would be expected with acoustic hearing aids. The results also demonstrate that many implanted children can participate in interactive tests with pre-recorded speech, thus providing robust data for comparison with future performance.

Adult↗
PubMed2000

Prone breast radiotherapy in early-stage breast cancer: a preliminary analysis.

PURPOSE: Women with large breasts have marked dose inhomogeneity and often an inferior cosmetic outcome when treated with breast conservation compared to smaller-sized patients. We designed a prone breast board, which both minimizes breast separation and irradiated lung or heart volume. We report feasibility, cosmesis, and preliminary local control and survival for selected women with Stage 0-II breast cancer. MATERIALS AND METHODS: Fifty-six patients with clinical Stage 0-II breast cancer were treated with lumpectomy and breast irradiation utilizing a prototype prone breast board. A total of 59 breasts were treated. Indications for treatment in the prone position were large or pendulous breast size (n = 57), or a history of cardiopulmonary disease (n = 2). The median bra size was 41D (range, 34D-44EE). Cosmesis was evaluated on a 1-10 (worst-to-best) scale. RESULTS: Acute toxicity included skin erythema (80% of patients experienced Grade I or Grade II erythema), breast edema (72% of patients experienced mild edema), pruritus (20% of patients), and fatigue (20% of patients reported mild fatigue). One patient required a treatment break. The only late toxicity was related to long-term cosmesis. The mean overall cosmesis score for 53 patients was 9.37 (range, 8-10). Actuarial 3- and 5-year local control rates are 98%. Actuarial overall survival at 3 and 5 years are 98% and 94%. CONCLUSION: Our data indicate that treating selected women with prone breast radiotherapy is feasible and tolerated. The approach results in excellent cosmesis, and short-term outcome is comparable to traditional treatment techniques. This technique offers an innovative alternative to women who might not otherwise be considered candidates for breast conservation.

Adult↗
PubMed2000

Common toxicity criteria: version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapy.

In 1997, the National Cancer Institute (NCI) led an effort to revise and expand the Common Toxicity Criteria (CTC) with the goal of integrating systemic agent, radiation, and surgical criteria into a comprehensive and standardized system. Representatives from the Radiation Therapy Oncology Group (RTOG) participated in this process in an effort to improve acute radiation related criteria and to achieve better clarity and consistency among modalities. CTC v. 2.0 replaces the previous NCI CTC and the RTOG Acute Radiation Morbidity Scoring Criteria and includes more than 260 individual adverse events with more than 100 of these applicable to acute radiation effects. One of the advantages of the revised criteria for radiation oncology is the opportunity to grade acute radiation effects not adequately captured under the previous RTOG system. A pilot study conducted by the RTOG indicated the new criteria are indeed more comprehensive and were preferred by research associates. CTC v. 2.0 represents an improvement in the evaluation and grading of acute toxicity for all modalities.

Antineoplastic Agents↗
PubMed2000

Early experience with the cochlear ESPrit ear-level speech processor in children.

The ESPrit ear-level speech processor has recently become available in the United Kingdom for use with the Nucleus CI24M multichannel cochlear implant. We report on the use of this ear-level processor with 6 children, ages 8 to 15 years. In this study, all patients were initially fitted with the SPrint body-worn processor, this being a prerequisite for programming the ESPrit. Five of the children were fitted successfully with the ESPrit and are using their devices consistently. The results show that patient experience with the ESPrit has been favorable, although there have been some device and programming difficulties. Aided threshold measures show that the ESPrit processor performs at least as well as the SPrint processor, with a trend toward improved aided thresholds for the ESPrit processor compared with the SPrint processor. Further study of the functional benefit of both of these devices may confirm these potential gains. The ESPrit device currently has a disadvantage for children in that it does not support FM radio hearing aid use. Finally, caution is advised in the fitting of the ESPrit in very young children or inexperienced listeners, because of difficulties in monitoring device function.

Adolescent↗
PubMed2000

Assessment of aided ABR thresholds before cochlear implantation.

The Nottingham Paediatric Cochlear Implant Programme (NPCIP) specializes in the cochlear implantation of children under the age of 5 years. The initial stage in the pre-implant evaluation process is audiological assessment. In complex paediatric cases, behavioural audiological assessment may be difficult. In such cases, an objective measure to verify the aided hearing threshold is desirable. This study compares unaided and aided hearing thresholds, by both objective and behavioural techniques, in 20 children (aged <1-10 years). Objective data were collected from auditory brainstem responses (ABR) and behavioural thresholds were measured by use of developmental age-appropriate tests. When comparing the unaided ABR click threshold to the behavioural threshold (obtained from the average of 1-4 kHz warble tones) the ABR threshold was, on average, 9 dB lower (more sensitive). Using the same comparison for aided responses a difference of <5 dB was observed. Unaided ABR thresholds resulted in 35% of subjects responding to the click stimulation (when using a maximum stimulation level of 105 dB nHL), whereas introducing aided ABR measurement elicited positive results in 75% of subjects. The effect of the hearing aid on the stimulus was measured by use of a 2 cc coupler which was connected to a precision sound level meter, whose AC output was recorded onto digital audiotape. Analysis of the resultant output spectra in the frequency domain highlighted signal non-linearity and distortion when using high-intensity stimuli with moderate to high aid gains. In conclusion, aided ABR thresholds are valuable in the management of young children. However, when performing either ABR or behavioural aided hearing threshold measurements it is essential to be aware of the limitations of the hearing aid and the stimulus.

Acoustic Impedance Tests↗